Abstract
Purpose
To investigate the relationship between health-related quality of life (HRQoL) and different cutoff value of low level of high-density lipoprotein cholesterol (HDL-C) in Taiwanese women with different definition of obesity.
Methods
Prospective observational study in women with central obesity was conducted in Taipei City Hospital. A total of 572 women were screened at our clinic, and 227 of them with a body mass index ≧27 kg/m2 defined by the Department of Health in Taiwan and weight circumference ≧80 cm were eligible for the study. We defined two groups as group A-low HDL (HDL-C < 40 mg/dL) and group B-high HDL (HDL-C < 50 mg/dL) according to different definition of hypoalphalipoproteinemia in obese women.
Results
Significantly reduced HRQoL score was noted in group A-low HDL compared to group A-high HDL (HDL-C ≧ 40 mg/dL), but not between group B-low HDL and group B-high HDL (HDL-C ≧ 50 mg/dL). Positively correlation was noted between HDL-C level and physical domain of HRQoL score. HDL-C contributes independently to physical domain of HRQoL score after controlling for other factors. Decreased leptin and adiponectin level were noted in hypoalphalipoproteinemia groups.
Conclusion
Taiwanese obese women with hypoalphalipoproteinemia have adverse impact on HRQoL, especially when the HDL-C level is lower than 40 mg/dL. Both hypoalphalipoproteinemia and hypertension accounted for a great variance to lower scores of physical domain of HRQoL with positively correlation with HDL-C level observed. Decreased leptin and adiponectin were also observed in hypoalphalipoproteinemia group, which implied increased cardiovascular risk. HDL-C level may deem as another indicator for HRQoL in women with central obesity.
Similar content being viewed by others
References
Friedrich, M. J. (2002). Epidemic of obesity expands its spread to developing countries. JAMA, 287(11), 1382–1386.
Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., & Dietz, W. H. (1999). The disease burden associated with overweight and obesity. JAMA, 282(16), 1523–1529.
Kolotkin, R. L., Meter, K., & Williams, G. R. (2001). Quality of life and obesity. Obesity Reviews, 2(4), 219–229.
Scaglione, R., Di Chiara, T., Cariello, T., & Licata, G. (2010). Visceral obesity and metabolic syndrome: two faces of the same medal? Internal and Emergency Medicine, 5(2), 111–119.
Paul, S., & Smith, L. (2005). The metabolic syndrome in women: a growing problem for cardiac risk. Journal of Cardiovascular Nursing, 20(6), 427–432.
Corica, F., Corsonello, A., Apolone, G., Mannucci, E., Lucchetti, M., Bonfiglio, C., et al. (2008). Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. International Journal of Obesity (London), 32(1), 185–191.
Katano, S., Nakamura, Y., Nakamura, A., Suzukamo, Y., Murakami, Y., Tanaka, T., et al. (2011). Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic components. Quality of Life Research, 21(7), 1165–1170.
Amiri, P., Hosseinpanah, F., Rambod, M., Montazeri, A., & Azizi, F. (2010). Metabolic syndrome predicts poor health-related quality of life in women but not in men: Tehran Lipid and Glucose Study. Journal of Womens Health (Larchmt), 19(6), 1201–1207.
Meigs, J. B. (2003). The metabolic syndrome. BMJ, 327(7406), 61–62.
Singh, V., Sharma, R., Kumar, A., & Deedwania, P. (2010). Low high-density lipoprotein cholesterol: current status and future strategies for management. Vascular Health and Risk Management, 6, 979–996.
National Cholesterol Education Program Expert Panel on Detection, E., & Treatment of High Blood Cholesterol in, A. (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106(25), 3143–3421.
Pan, W. H., Lee, M. S., Chuang, S. Y., Lin, Y. C., & Fu, M. L. (2008). Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obesity Reviews, 9(Suppl 1), 22–31.
Yao, G., Chung, C. W., Yu, C. F., & Wang, J. D. (2002). Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. Journal of the Formosan Medical Association, 101(5), 342–351.
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419.
Schlotz, W., Ambery, P., Syddall, H. E., Crozier, S. R., Sayer, A. A., Cooper, C., et al. (2007). Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Quality of Life Research, 16(3), 429–436.
Chedraui, P., Hidalgo, L., Chavez, D., Morocho, N., Alvarado, M., & Huc, A. (2007). Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas, 56(1), 45–53.
Ford, E. S., & Li, C. (2008). Metabolic syndrome and health-related quality of life among U.S. adults. Annals of Epidemiology, 18(3), 165–171.
Park, S. S., Yoon, Y. S., & Oh, S. W. (2011). Health-related quality of life in metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2005. Diabetes Research and Clinical Practice, 91(3), 381–388.
Lalonde, L., O’Connor, A., Joseph, L., Grover, S. A., & Canadian Collaborative Cardiac Assessment Group. (2004). Health-related quality of life in cardiac patients with dyslipidemia and hypertension. Quality of Life Research, 13(4), 793–804.
Lamarche, B., Despres, J. P., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P. J. (1996). Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis, 119(2), 235–245.
Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., Breslow, J. L., & Buring, J. E. (1997). Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96(8), 2520–2525.
Qian, Y., Lin, Y., Zhang, T., Bai, J., Chen, F., Zhang, Y., et al. (2010). The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population. BMC Public Health, 10, 139.
von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P. P., Brenner, H., & Rothenbacher, D. (2006). Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clinical Chemistry, 52(5), 853–859.
Kazumi, T., Kawaguchi, A., Hirano, T., & Yoshino, G. (2004). Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism, 53(5), 589–593.
Matsubara, M., Maruoka, S., & Katayose, S. (2002). Decreased plasma adiponectin concentrations in women with dyslipidemia. Journal of Clinical Endocrinology and Metabolism, 87(6), 2764–2769.
Nogueira, J. P., Maraninchi, M., Beliard, S., Lorec, A. M., Berthet, B., Begu-Le Corroller, A., et al. (2012). Unacylated Ghrelin is associated with the isolated low HDL-cholesterol obese phenotype independently of insulin resistance and CRP level. Nutrition and Metabolism (Lond), 9(1), 17.
Marinari, G. M., Scopinaro, N., & Adami, G. F. (2001). Leptin and HDL-cholesterol in non-diabetic normotensive subjects. Obesity Surgery, 11(3), 252–253.
Park, K. G., Park, K. S., Kim, M. J., Kim, H. S., Suh, Y. S., Ahn, J. D., et al. (2004). Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Research and Clinical Practice, 63(2), 135–142.
Yadav, A., Jyoti, P., Jain, S. K., & Bhattacharjee, J. (2011). Correlation of adiponectin and leptin with insulin resistance: a pilot study in healthy north Indian population. Indian Journal of Clinical Biochemistry, 26(2), 193–196.
Ostlund, R. E., Jr, Yang, J. W., Klein, S., & Gingerich, R. (1996). Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. Journal of Clinical Endocrinology and Metabolism, 81(11), 3909–3913.
Acknowledgments
We thank all our colleagues in Taipei City Hospital, Taiwan, for helping with this study. This study was supported by grants from Taipei City Hospital.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, IJ., Lin, WC., Liu, CY. et al. Impact of hypoalphalipoproteinemia on quality of life in Taiwanese women with central obesity. Qual Life Res 23, 1619–1627 (2014). https://doi.org/10.1007/s11136-013-0601-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0601-8